These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32433820)

  • 1. FOXO1 suppresses PGC-1β gene expression in skeletal muscles.
    Nakai S; Oyabu M; Hatazawa Y; Akashi S; Kitamura T; Miura S; Kamei Y
    FEBS Open Bio; 2020 Jul; 10(7):1373-1388. PubMed ID: 32433820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-II-mediated downregulation of peroxisome proliferator-activated receptor-γ coactivator-1α in myoblast cells involves PI3K/Akt/FoxO1 signaling pathway.
    Mu X; Qi W; Liu Y; Zhou J; Li Y; Rong X; Lu L
    Mol Cell Biochem; 2017 Aug; 432(1-2):199-208. PubMed ID: 28374141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXO1 delays skeletal muscle regeneration and suppresses myoblast proliferation.
    Yamashita A; Hatazawa Y; Hirose Y; Ono Y; Kamei Y
    Biosci Biotechnol Biochem; 2016 Aug; 80(8):1531-5. PubMed ID: 27010781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGC-1alpha gene expression is down-regulated by Akt- mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle.
    Southgate RJ; Bruce CR; Carey AL; Steinberg GR; Walder K; Monks R; Watt MJ; Hawley JA; Birnbaum MJ; Febbraio MA
    FASEB J; 2005 Dec; 19(14):2072-4. PubMed ID: 16203862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control.
    Kamei Y; Miura S; Suzuki M; Kai Y; Mizukami J; Taniguchi T; Mochida K; Hata T; Matsuda J; Aburatani H; Nishino I; Ezaki O
    J Biol Chem; 2004 Sep; 279(39):41114-23. PubMed ID: 15272020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cathepsin L gene is a direct target of FOXO1 in skeletal muscle.
    Yamazaki Y; Kamei Y; Sugita S; Akaike F; Kanai S; Miura S; Hirata Y; Troen BR; Kitamura T; Nishino I; Suganami T; Ezaki O; Ogawa Y
    Biochem J; 2010 Mar; 427(1):171-8. PubMed ID: 20088826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription.
    Sandri M; Lin J; Handschin C; Yang W; Arany ZP; Lecker SH; Goldberg AL; Spiegelman BM
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16260-5. PubMed ID: 17053067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGC-1β modulates statin-associated myotoxicity in mice.
    Singh F; Zoll J; Duthaler U; Charles AL; Panajatovic MV; Laverny G; McWilliams TG; Metzger D; Geny B; Krähenbühl S; Bouitbir J
    Arch Toxicol; 2019 Feb; 93(2):487-504. PubMed ID: 30511338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGC-1α over-expression suppresses the skeletal muscle atrophy and myofiber-type composition during hindlimb unloading.
    Wang J; Wang F; Zhang P; Liu H; He J; Zhang C; Fan M; Chen X
    Biosci Biotechnol Biochem; 2017 Mar; 81(3):500-513. PubMed ID: 27869526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGC-1α functions as a co-suppressor of XBP1s to regulate glucose metabolism.
    Lee J; Salazar Hernández MA; Auen T; Mucka P; Lee J; Ozcan U
    Mol Metab; 2018 Jan; 7():119-131. PubMed ID: 29129613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sepsis and glucocorticoids downregulate the expression of the nuclear cofactor PGC-1beta in skeletal muscle.
    Menconi MJ; Arany ZP; Alamdari N; Aversa Z; Gonnella P; O'Neal P; Smith IJ; Tizio S; Hasselgren PO
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E533-43. PubMed ID: 20647557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXO1 cooperates with C/EBPδ and ATF4 to regulate skeletal muscle atrophy transcriptional program during fasting.
    Oyabu M; Takigawa K; Mizutani S; Hatazawa Y; Fujita M; Ohira Y; Sugimoto T; Suzuki O; Tsuchiya K; Suganami T; Ogawa Y; Ishihara K; Miura S; Kamei Y
    FASEB J; 2022 Feb; 36(2):e22152. PubMed ID: 35061305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoform-specific increases in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to beta2-adrenergic receptor activation and exercise.
    Miura S; Kai Y; Kamei Y; Ezaki O
    Endocrinology; 2008 Sep; 149(9):4527-33. PubMed ID: 18511502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of forkhead box O1 in renal tubular epithelial cells on endotoxin-induced acute kidney injury.
    Zhang M; Dong W; Li Z; Xiao Z; Xie Z; Ye Z; Liu S; Li R; Chen Y; Zhang L; Wang M; Liang H; Baihetiyaer R; Apaer R; Dong Z; Liang X
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F262-F272. PubMed ID: 33356954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone activation by type 2 deiodinase mediates exercise-induced peroxisome proliferator-activated receptor-γ coactivator-1α expression in skeletal muscle.
    Bocco BM; Louzada RA; Silvestre DH; Santos MC; Anne-Palmer E; Rangel IF; Abdalla S; Ferreira AC; Ribeiro MO; Gereben B; Carvalho DP; Bianco AC; Werneck-de-Castro JP
    J Physiol; 2016 Sep; 594(18):5255-69. PubMed ID: 27302464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prmt7 Deficiency Causes Reduced Skeletal Muscle Oxidative Metabolism and Age-Related Obesity.
    Jeong HJ; Lee HJ; Vuong TA; Choi KS; Choi D; Koo SH; Cho SC; Cho H; Kang JS
    Diabetes; 2016 Jul; 65(7):1868-82. PubMed ID: 27207521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle.
    Jørgensen SB; Wojtaszewski JF; Viollet B; Andreelli F; Birk JB; Hellsten Y; Schjerling P; Vaulont S; Neufer PD; Richter EA; Pilegaard H
    FASEB J; 2005 Jul; 19(9):1146-8. PubMed ID: 15878932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult expression of PGC-1α and -1β in skeletal muscle is not required for endurance exercise-induced enhancement of exercise capacity.
    Ballmann C; Tang Y; Bush Z; Rowe GC
    Am J Physiol Endocrinol Metab; 2016 Dec; 311(6):E928-E938. PubMed ID: 27780821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fenofibrate and its combination with lovastatin on the expression of genes involved in skeletal muscle atrophy, including FoxO1 and its targets.
    Ajima H; Kai Y; Fujimaki J; Akashi S; Morita A; Ezaki O; Kamei Y; Miura S
    J Toxicol Sci; 2021; 46(1):11-24. PubMed ID: 33408297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.